ALEXION PHARMA SPAIN SLU
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 8
- Amount won alone
- €29,349,541 excl. VAT
- Shared contracts
- 1 (multi-supplier framework agreements)
- Period
- 15 July 2026 – 9 October 2026
Its main clients
- HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS · 2 contracts
- HOSPITAL CLINICO SAN CARLOS DE MADRID · 1 contract
- ENTE PÚBLICO HOSPITAL UNIVERSITARIO DE FUENLABRA · 1 contract
- Consorci Hospital Clínic de Barcelona (HCB) · 1 contract
- Servicio Madrileño de Salud - Hospital Universitario La Paz · 1 contract
- Servicio Cántabro de Salud · 1 contract
- Consorci de Salut i d'Atenció Social de Catalunya · 1 contract
Where and what
Supplies · 8
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 27 May 2027 re-tender around November 2026 |
Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).
Servicio Madrileño de Salud - Hospital Universitario La Paz |
ALEXION PHARMA SPAIN S.L.U. 1 bid received |
€2,603,216 |
| 9 September 2027 re-tender around March 2027 |
2026-94 Suministro de medicamentos exclusivos diversos de Alexion Pharma Spain, S.L.
Consorci Hospital Clínic de Barcelona (HCB) framework agreement |
ALEXION PHARMA SPAIN SLU 1 bid received |
€20,964,872 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.